News
ORGO
2.410
-6.95%
-0.180
Weekly Report: what happened at ORGO last week (0504-0508)?
Weekly Report · 5d ago
Organogenesis Earnings Call: Deep Pain, Long Road
TipRanks · 05/09 00:58
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga · 05/08 12:05
Forward Air Posts Downbeat Q1 Results, Joins Upwork, HubSpot And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Benzinga · 05/08 12:02
BTIG downgrades Organogenesis Holdings (ORGO) to a Hold
TipRanks · 05/08 11:27
Organogenesis downgraded to Neutral from Buy at BTIG
TipRanks · 05/08 11:17
ORGANOGENESIS HOLDINGS INC <ORGO.O>: BTIG CUTS TO NEUTRAL FROM BUY
Reuters · 05/08 11:06
Organogenesis forecasts $270M-$310M 2026 revenue amid prolonged CMS-related recovery
Seeking Alpha · 05/08 09:22
Organogenesis Q1 revenue misses estimates on lower wound care sales
Reuters · 05/07 20:40
Organogenesis Holdings Lowers FY2026 Sales Guidance from $350.000M-$420.000M to $270.000M-$310.000M vs $401.200M Est
Benzinga · 05/07 20:26
Here are the major earnings after the close Thursday
Seeking Alpha · 05/07 14:00
Weekly Report: what happened at ORGO last week (0427-0501)?
Weekly Report · 05/04 09:02
Organogenesis Completed Rolling BLA Submission For ReNu For Knee Osteoarthritis
NASDAQ · 04/29 02:30
Organogenesis completes rolling submission of ReNu BLA
TipRanks · 04/28 22:00
Organogenesis completes FDA BLA submission for ReNu knee osteoarthritis therapy
PUBT · 04/28 21:04
ORGANOGENESIS COMPLETES ROLLING SUBMISSION OF BIOLOGICS LICENSE APPLICATION FOR RENU®
Reuters · 04/28 20:30
Weekly Report: what happened at ORGO last week (0420-0424)?
Weekly Report · 04/27 09:03
Weekly Report: what happened at ORGO last week (0413-0417)?
Weekly Report · 04/20 09:02
Weekly Report: what happened at ORGO last week (0406-0410)?
Weekly Report · 04/13 09:03
Weekly Buzz: MGNX Resumes LINNET; GSK Wins China Nod; FDA Okays Waters; NBIX Snaps Up SLNO
NASDAQ · 04/10 14:00
More
Webull provides a variety of real-time ORGO stock news. You can receive the latest news about Organogenesis Hldgs Inc through multiple platforms. This information may help you make smarter investment decisions.
About ORGO
Organogenesis Holdings Inc. is a regenerative medicine company focused on the development, manufacture and commercialization of solutions for the advanced wound care and surgical and sports medicine markets. It offers a portfolio of regenerative products to address patient needs across the continuum of care. Its wound care products include Apligraf for the treatment of venous leg ulcers and diabetic foot ulcers (DFUs); Dermagraft for the treatment of DFUs; PuraPly AM as an antimicrobial barrier, cross-linked with extracellular matrix scaffold for a variety of wound types; and Affinity, Novachor and NuShield placental allografts to address a variety of wound sizes and types as a protective barrier and extracellular matrix scaffold. Its sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM and PuraPly SX for the management of open wounds in a surgical setting.